Harel Insurance Investments & Financial Services Ltd. Atea Pharmaceuticals, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 07, 2022	SELL	$7.67 - $44.59 $153,400 - $891,800	-20,000 Closed	0 $0
Q3 2021 Oct 25, 2021	BUY	$21.33 - $35.06 $426,599 - $701,200	20,000 New	20,000 $701,000

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

Black Rock Inc. New York, NY

9.12M
Shares

$30.1 Million
0.0% of portfolio
Bml Capital Management, LLC Zionsville, IN

6.65M
Shares

$21.9 Million
13.11% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.44M
Shares

$18 Million
0.79% of portfolio
Vanguard Group Inc Valley Forge, PA

4.85M
Shares

$16 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

4.61M
Shares

$15.2 Million
1.31% of portfolio

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $275M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account